Compound library / Fat Loss / GLP-1
Once-weekly GLP-1 receptor agonist, FDA-approved for type 2 diabetes and cardiovascular risk reduction.
| Category | Fat Loss / GLP-1 |
|---|---|
| Typical route | Subcutaneous |
| Half-life | ~5 days |
| Common dose range | 0.75-4.5 mg/week |
| Typical cycle length | Ongoing under medical supervision |
BioHack Track models Dulaglutide (Trulicity) at a half-life of 120 hours, so every dose you log is decayed against that curve and the app shows what is still circulating — not just what you typed.
Supplied pre-filled in an auto-injector pen; no reconstitution needed.
Refrigerate; stable at room temperature for a limited time per label.
Prescription medication. Same GI and thyroid C-cell warnings as other GLP-1 drugs.
Track Dulaglutide (Trulicity) in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for Dulaglutide (Trulicity) — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.